Anthony E. Dragun , M.D.

Multidisciplinary Clinic
Breast

Clinical Expertise
Breast Cancer
Radiation Oncology

Education

2002-2003
Intern: Transitional Internship
Temple University, Crozer-Chester Medical Center, Chester, PA

1998-2002               
MCP-Hahnemann University School of Medicine
Philadelphia, PA
Doctor of Medicine
Summa Cum Laude

1993-1997                
Colgate University
Hamilton, NY
Bachelor of Arts, Molecular Biology
Cum Laude, Honors in Molecular Biology

Research Interest

•  RTOG 0413/NSABP B-39: A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer
  • National cooperative group protocol; Open and Accruing: July 2009-Present

• BCC-AHFRT-10: A Phase II Study of Accelerated Hypofractionated Radiotherapy (AHF-RT) after Breast Conserving Surgery (BCS).
  •  Investigator initiated protocol; Open and Accruing: December 2010-Present

Publications

1.        Dragun AE. “Early Stage Breast Cancer.” Encyclopedia of Radiation Oncology: First Edition (eds. Brady LW, Yeager T) February 2010 In Press. (Springer, Heidelberg, Germany).

2.        Dragun AE. “Locally Advanced and Recurrent Breast Cancer, Systemic Therapy.” Encyclopedia of Radiation Oncology: First Edition (eds. Brady LW, Yeager T) February 2010 In Press. (Springer, Heidelberg, Germany).

1.        Dragun AE. Commentary: Population-based analysis of occult primary breast cancer with axillary lymph node metastasis. In Press. Breast Diseases: a Year Book Quarterly.

2.        Dragun AE, Huang B, Tucker TC, et al. Disparities in the application of adjuvant radiotherapy (RT) after breast conserving surgery (BCS) for early-stage breast cancer impact overall survival. Cancer. 2010 December 10.[Epub ahead of print].